Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PUT
Altria Group
MO
$110B
| $149M | 0.07% |
2,356,300
+345,000
| +17% | +$22.9M |
|
227
CALL
Philip Morris
PM
$293B
| $148M | 0.07% |
1,525,800
-341,600
| -18% | -$34.2M |
|
228
PUT
Sarepta Therapeutics
SRPT
$1.98B
| $148M | 0.07% |
2,415,300
-193,000
| -7% | -$5.83M |
|
229
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$22B
| $148M | 0.07% |
6,036,200
-617,200
| -9% | -$15.7M |
|
|
230
CALL
Altria Group
MO
$110B
| $148M | 0.07% |
2,334,700
-250,200
| -10% | -$16.6M |
|
231
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $147M | 0.07% |
1,684,700
-2,838,100
| -63% | -$244M |
|
232
CALL
iShares US Real Estate ETF
IYR
$4.62B
| $146M | 0.07% |
1,814,000
-748,200
| -29% | -$61.9M |
|
233
PUT
Molson Coors Class B
TAP
$8.01B
| $146M | 0.07% |
1,329,200
+1,104,100
| +490% | +$112M |
|
234
PUT
Coty
COTY
$2.41B
| $146M | 0.07% |
6,192,600
+6,066,500
| +4,811% | +$160M |
|
235
CALL
ConocoPhillips
COP
$162B
| $145M | 0.07% |
3,345,400
-420,000
| -11% | -$17.4M |
|
236
CALL
Palo Alto Networks
PANW
$292B
| $144M | 0.07% |
5,417,400
-778,200
| -13% | -$17.7M |
|
|
237
CALL
Bristol-Myers Squibb
BMY
$137B
| $142M | 0.07% |
2,636,200
-355,400
| -12% | -$22.8M |
|
238
CALL
Nike
NKE
$60.5B
| $142M | 0.07% |
2,691,800
-1,078,300
| -29% | -$60.9M |
|
239
PUT
State Street Financial Select Sector SPDR ETF
XLF
$56B
| $142M | 0.07% |
7,339,000
-5,398,475
| -42% | -$111M |
|
240
PUT
Oracle
ORCL
$422B
| $142M | 0.07% |
3,602,900
+816,400
| +29% | +$33.3M |
|
|
SHPG
241
CALL
DELISTED
Shire pic
SHPG
| $141M | 0.07% |
729,200
-696,300
| -49% | -$136M |
|
242
PUT
Expedia Group
EXPE
$38.6B
| $140M | 0.07% |
1,203,700
+55,700
| +5% | +$6.3M |
|
243
iShares 20+ Year Treasury Bond ETF
TLT
$46.3B
| $140M | 0.07% |
1,021,548
+1,018,753
| +36,449% | +$141M |
|
|
DD
244
CALL
DELISTED
Du Pont De Nemours E I
DD
| $140M | 0.07% |
2,096,200
-610,500
| -23% | -$41.5M |
|
245
CALL
Intuitive Surgical
ISRG
$134B
| $139M | 0.07% |
1,728,900
-156,600
| -8% | -$12M |
|
246
iShares China Large-Cap ETF
FXI
$4.28B
| $138M | 0.07% |
+3,640,085
| New | +$133M |
|
247
AB InBev
BUD
$155B
| $137M | 0.07% |
1,038,800
+687,170
| +195% | +$86.8M |
|
248
PUT
Delta Air Lines
DAL
$54.2B
| $136M | 0.07% |
3,458,000
-1,316,500
| -28% | -$49.8M |
|
|
PARA
249
CALL
DELISTED
Paramount Global Class B
PARA
| $136M | 0.07% |
2,478,200
-68,200
| -3% | -$3.62M |
|
250
CALL
MetLife
MET
$60B
| $135M | 0.07% |
3,397,865
+395,393
| +13% | +$14.9M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.